|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term deposits | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses and other receivables | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payables | ||||||||||||||||||||
| Convertible loans | ||||||||||||||||||||
| Loans from related party | ||||||||||||||||||||
| Fair value of convertible component in convertible loans | ||||||||||||||||||||
| Other accounts liabilities | ||||||||||||||||||||
| Short term lease liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| Ordinary shares of $0.0001 par value Authorized: 500,000,000 shares at June 30, 2026 and December 31, 2025; Issued and Outstanding: 4,215,571 and 4,215,571 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional Paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Shareholders’ deficit | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
